GENinCode Plc (LON:GENI – Get Free Report) shares hit a new 52-week low during trading on Friday . The company traded as low as GBX 3.20 ($0.04) and last traded at GBX 3.40 ($0.04), with a volume of 59570 shares trading hands. The stock had previously closed at GBX 3.60 ($0.04).
GENinCode Price Performance
The company has a market capitalization of £6.02 million, a price-to-earnings ratio of -68.00 and a beta of 0.66. The business has a fifty day moving average price of GBX 3.95 and a 200 day moving average price of GBX 5.35. The company has a debt-to-equity ratio of 9.27, a current ratio of 2.60 and a quick ratio of 15.89.
GENinCode Company Profile
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
See Also
- Five stocks we like better than GENinCode
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- What is the FTSE 100 index?
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
